- Home
- IBG vs BDRX Comparison
IBG vs BDRX Comparison
Compare IBG & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBG | BDRX |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | Australia | United Kingdom |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.6M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | IBG | BDRX |
|---|---|---|
| Price | $0.96 | $1.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 56.6K | ★ 263.0K |
| Earning Date | 05-12-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $0.60 |
| 52 Week High | $6.50 | $11.88 |
Technical Indicators
Market Signals| Indicator | IBG | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 19.77 |
| Support Level | $0.99 | $0.60 |
| Resistance Level | $1.08 | $1.50 |
| Average True Range (ATR) | 0.09 | 0.11 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 74.06 | 7.22 |
Price Performance
Historical ComparisonAbout IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.